Plassche Douglas

SVP of OperationsELITE PHARMACEUTICALS INC /NV/ (ELTP) · full profile →Form 4 · filed Oct 28, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$562K
Net Open-Market Flow
-$562K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 24, 2024Sell(S)334K$0.51$170K0
Oct 23, 2024Sell(S)800K$0.49$392K334K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-042726) within minutes of acceptance. Every field above traces to the original document. Verify it directly: